Blog
RSS FeedPosted by Michael Wonder on 22 Sep 2016
43p drug that prevents spread of breast cancer denied to thousands
22 September 2016 - Thousands of women in the UK with breast cancer are being denied a 43p-a-day medicine ...
Posted by Michael Wonder on 22 Sep 2016
NICE to recommend new drug to treat rare inherited bone disorder in children
22 September 2016 - NICE recommends ‘lifeline’ drug for babies and young children, in draft guidance. ...
Posted by Michael Wonder on 19 Sep 2016
NICE says no to expanding scope of Roche’s IPF drug
19 September 2016 - Patients in England and Wales with the lung scarring disease idiopathic pulmonary fibrosis will have to wait ...
Posted by Michael Wonder on 15 Sep 2016
NICE published draft guidance on new use for Gazyva
15 September 2016 - The Department of Health has asked the NICE to produce guidance on using obinutuzumab in combination with ...
Posted by Michael Wonder on 09 Sep 2016
More options to be made available to treat hepatitis C
9 September 2016 - Another ‘potential curative’ drug for people with chronic hepatitis C will be made available on the NHS. ...
Posted by Michael Wonder on 08 Sep 2016
Coil is more effective than pill as emergency contraception, says NICE
8 September 2016 - NICE is calling for women to be told that the coil is more effective than the ‘morning ...
Posted by Michael Wonder on 06 Sep 2016
NICE rejects Roche’s melanoma combination
6 September 2016 - Patients in England and Wales with melanoma will not be getting routine access to Roche's Cotellic/Zelboraf combination ...
Posted by Michael Wonder on 03 Sep 2016
NICE recommends Cancer Drugs Fund treatment for prostate cancer for routine NHS use
2 September 2016 - More prostate cancer patients will receive radium 223 after NICE approved it for routine NHS use. ...
Posted by Michael Wonder on 26 Aug 2016
NICE backs non-surgical option for fibroids
26 August 2016 - Women with uterine fibroids stand to gain routine access to a non-surgical treatment on the NHS for ...
Posted by Michael Wonder on 25 Aug 2016
NICE recommends Servier's Lonsurf (trifluridine with tipiracil hydrochloride)
24 August 2016 - New treatment for patients with advanced colorectal cancer. ...
Posted by Michael Wonder on 24 Aug 2016
NICE issues draft guidance on the use of Eylea (afilbercept)
24 August 2016 - NICE has issued draft final guidance on the use of Bayer's Eylea (aflibercept) on the NHS. ...
Posted by Michael Wonder on 24 Aug 2016
NICE approves new cancer drugs for routine NHS use
24 August 2016 - Two cancer treatments, previously only available to patients through the Cancer Drugs Fund, will now be routinely ...
Posted by Michael Wonder on 23 Aug 2016
Rare blood cancer therapy Oncaspar gets NICE green light
23 August 2016 - Treatment from Baxalta/Shire for patients with acute lymphoblastic leukaemia recommended by NICE for use on the ...
Posted by Michael Wonder on 19 Aug 2016
NICE issues draft guidance on the first-line use of sorafenib tosylate (Nexavar) in advanced/metastatic hepatocellular carcinoma
19 August 2016 - The merits of Nexavar in liver cancer have been reviewed by NICE under the CDF rapid reconsideration ...
Posted by Michael Wonder on 18 Aug 2016
Subsidised access to new melanoma drugs: in need of further innovation?
19 August 2016 - New Zealand is now the melanoma capital of the world but is behind the rest of ...